The General Hospital Corporation Research Management Division, doing business as Massachusetts General Hospital (MGH), was awarded a $1,644,309 Project Grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) to conduct research on "FUNCTIONAL MOLECULAR NETWORKS MODIFYING HIF2A ACTIVITY IN VHL TUMORS". The award, effective February 1, 2025, will support MGH's biomedical research efforts to advance the understanding and treatment of this type of cancer over the 3-year performance period ending January 31, 2028. As a leading academic medical center and longtime recipient of federal research funding, MGH will leverage its specialized facilities and expertise to carry out this project, potentially involving sub-awards to collaborate with other institutions as part of a multi-faceted research initiative.
Generated 3/4/25, 5:50 AM